文摘
Tubulin-伪1A/1B C-terminal tail (CTT) has seven glutamic acid residues among the last 11 amino acids of its sequence that are potential sites for glutamylation. Cleavage of C-terminal tyrosine resulting in the detyrosinated form of tubulin-伪1A/1B is another major modification. These modifications among others bring about highly heterogeneous tubulin samples in brain cells and microtubules, play a major role in directing intracellular trafficking, microtubule dynamics, and mitotic events, and can vary depending on the cell and disease state, such as cancer and neurodegenerative disorders. Identified previously using primary mass spectrometry (MS) ions and partial Edman sequencing, tubulin-伪1A/1B glutamylation was found exclusively on the E445 residue. We here describe the analysis of tubulin-伪1A/1B glutamylation and detyrosination after 2-DE separation, trypsin and proteinase K in-gel digestion, and nanoUPLC-ESI-QqTOF-MS/MS of mouse brain and bovine microtubules. Tyrosinated, detyrosinated, and 螖2-tubulin-伪1A/1B CTTs were identified on the basis of a comparison of fragmentation patterns and retention times between endogenous and synthetic peptides. Stringent acceptance criteria were adapted for the identification of novel glutamylation sites. In addition to the previously identified site at E445, glutamylation on mouse and bovine tubulin-伪1A/1B CTTs was identified on E441 and E443 with MASCOT Expect values below 0.01. O-Methylation of glutamates was also observed.
Keywords:
AGBL2; detyrosination; glutamylation; tandem hybrid mass spectrometry; tubulin methylation; microtubule targetting drugs (MTTDs); nano-LC; proteinase K; tubulin-alpha; tubulin C-terminal tail